Recent advancements in mechanical reduction methods: particulate systems (Q38132471)

29 August 2017

Recent advancements in mechanical reduction methods: particulate systems (English)

1 reference

29 August 2017

Jardin Leleux

1

1 reference

PubMed ID

23988193

29 August 2017

Robert O Williams

series ordinal

2

1 reference

PubMed ID

23988193

29 August 2017

language of work or name

English

0 references

publication date

30 August 2013

1 reference

Drug Development and Industrial Pharmacy

29 August 2017

1 reference

29 August 2017

40

1 reference

29 August 2017

3

1 reference

29 August 2017

289-300

1 reference

Drug nanoparticles: formulating poorly water-soluble compounds

29 August 2017

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Formulation design for poorly water-soluble drugs based on biopharmaceutics classification system: basic approaches and practical applications

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

The influence of co-solvents on the stability and bioavailability of rapamycin formulated in self-microemulsifying drug delivery systems.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

A formulation comparison between micro- and nanosuspensions: the importance of particle size for absorption of a model compound, following repeated oral administration to rats during early development

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Effect of particle size reduction on dissolution and oral absorption of a poorly water-soluble drug, cilostazol, in beagle dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Effects of food on clinical pharmacokinetics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Mechanisms underlying food-drug interactions: inhibition of intestinal metabolism and transport.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

The pharmacokinetics of nebulized nanocrystal budesonide suspension in healthy volunteers.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Formulation and pharmacokinetic evaluation of an asulacrine nanocrystalline suspension for intravenous delivery

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Preparation and characterization of intravenously injectable curcumin nanosuspension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Particle design of poorly water-soluble drug substances using supercritical fluid technologies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Nanoparticles in the pharmaceutical industry and the use of supercritical fluid technologies for nanoparticle production

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

A comparative study of top-down and bottom-up approaches for the preparation of micro/nanosuspensions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Nanocrystals: industrially feasible multifunctional formulation technology for poorly soluble actives

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Nanoparticulation of poorly water soluble drugs using a wet-mill process and physicochemical properties of the nanopowders

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Continuous production of drug nanoparticle suspensions via wet stirred media milling: a fresh look at the Rehbinder effect

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Pharmaceutical nanocrystals by nanomilling: critical process parameters, particle fracturing and stabilization methods

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Nanoparticle engineering processes for enhancing the dissolution rates of poorly water soluble drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Nanosizing--oral formulation development and biopharmaceutical evaluation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Nanosizing for oral and parenteral drug delivery: a perspective on formulating poorly-water soluble compounds using wet media milling technology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

A new fenofibrate formulation: results of six single-dose, clinical studies of bioavailability under fed and fasting conditions

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Development of a long-acting injectable formulation with nanoparticles of rilpivirine (TMC278) for HIV treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Phase I trial of 2-methoxyestradiol NanoCrystal dispersion in advanced solid malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

A formulation strategy for gamma secretase inhibitor ELND006, a BCS class II compound: development of a nanosuspension formulation with improved oral bioavailability and reduced food effects in dogs

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Development of an intravenously injectable chemically stable aqueous omeprazole formulation using nanosuspension technology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Nanosuspension formulations for low-soluble drugs: pharmacokinetic evaluation using spironolactone as model compound

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Pharmacokinetic evaluation of oral fenofibrate nanosuspensions and SLN in comparison to conventional suspensions of micronized drug

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Nanonization of itraconazole by high pressure homogenization: stabilizer optimization and effect of particle size on oral absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Development and in vitro evaluation of deacety mycoepoxydiene nanosuspension

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Development of a chemically stable 10-hydroxycamptothecin nanosuspensions.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Drug Nano‐ and Microparticles Processed into Solid Dosage Forms: Physical Properties

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Conversion of nanosuspensions into dry powders by spray drying: a case study

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

A novel bottom-up process to produce drug nanocrystals: controlled crystallization during freeze-drying

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Preparation of drug nanocrystals by controlled crystallization: application of a 3-way nozzle to prevent premature crystallization for large scale production.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Process optimization of a novel production method for nanosuspensions using design of experiments (DoE).

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Nanocrystals: comparison of the size reduction effectiveness of a novel combinative method with conventional top-down approaches

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

In vitro inhibition of fungal activity by macrophage-mediated sequestration and release of encapsulated amphotericin B nanosupension in red blood cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Stable nanocolloids of poorly soluble drugs with high drug content prepared using the combination of sonication and layer-by-layer technology

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Sonication-assisted synthesis of polyelectrolyte-coated curcumin nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Top-down and bottom-up approaches in production of aqueous nanocolloids of low solubility drug paclitaxel.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Development of a novel ultra cryo-milling technique for a poorly water-soluble drug using dry ice beads and liquid nitrogen

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Laser fabrication and spectroscopy of organic nanoparticles.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Fabrication of paclitaxel nanocrystals by femtosecond laser ablation and fragmentation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Nanonization of megestrol acetate by laser fragmentation in aqueous milieu

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Preparation of polymeric nanoparticles of cyclosporin A using infrared pulsed laser

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Effect of novel stabilizers--cationic polymers on the particle size and physical stability of poorly soluble drug nanocrystals

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Characteristics of polymers enabling nano-comminution of water-insoluble drugs.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Poly(D,L-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Development and characterization of PLGA nanospheres and nanocapsules containing xanthone and 3-methoxyxanthone.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Efficient entrapment of poorly water-soluble pharmaceuticals in hybrid nanoparticles

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Nanotechnological advances for the delivery of CNS therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Solid lipid nanoparticles and nanosuspension formulation of Saquinavir: preparation, characterization, pharmacokinetics and biodistribution studies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Development of lipid-based nanoparticles for enhancing the oral bioavailability of paclitaxel.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Enhanced oral paclitaxel bioavailability after administration of paclitaxel-loaded lipid nanocapsules

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

The role of biopharmaceutics in the development of a clinical nanoparticle formulation of MK-0869: a Beagle dog model predicts improved bioavailability and diminished food effect on absorption in human

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

Nanoparticulation of probucol, a poorly water-soluble drug, using a novel wet-milling process to improvein vitrodissolution andin vivooral absorption

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F03639045.2013.828217

10.3109/03639045.2013.828217

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference

PubMed ID

23988193